Alessandra Falda

Dr. Alessandra Falda

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2004 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
FFFabio Farinati
Fabio Farinati
RCRomilda Cardin
Romilda Cardin
VRValentina Russo
Valentina Russo
GBGraziella Busatto
Graziella Busatto
MFMonica Franco
Monica Franco
MRMassimo Rugge
Massimo Rugge
Background and Aim: Helicobacter pylori–associated gastritis causes accumulation of reactive oxygen species in the mucosal compartment. This prospective study evaluates DNA oxidative damage in biopsy samples obtained from both the antrum and the gastroesophageal junction (GEJ) before and after H. pylori eradication. Patients and Methods: Thirty-two consecutive H. pylori–positive patients underwent endoscopy with multiple biopsy sampling (i.e., antrum, incisura angularis, fundus, and cardia at the GEJ). After H. pylori eradication, 32 patients underwent a checkup endoscopy (mean interval, 5.7 months); in a subgroup of 13 subjects, a third endoscopy procedure was also performed (mean interval, 18 months). Additional biopsy samples (two from the antrum and two from the GEJ) were used to assess 8-hydroxydeoxyguanosine (8OHdG) levels using both high-pressure liquid chromatography with electrochemical detector and ELISA. Results: In the antral compartment, no significant modifications of 8OHdG levels were assessed after H. pylori eradication. Conversely, following eradication, 8OHdG levels significantly increased (high-pressure liquid chromatography with electrochemical detector, P = 0.04; ELISA method, P = 0.05) in biopsy samples taken from the GEJ, and a further increase was documented in the subgroup of patients who underwent a third endoscopy (P = 0.01). The increasing trend was more relevant in patients in whom H. pylori-cagA–positive strains were eradicated and in those affected by hiatal hernia. Conclusions: The levels of DNA adducts in the antral mucosa are not modified by H. pylori eradication; conversely, H. pylori eradication significantly increases the oxidative adducts at the GEJ. The clinical and biological importance of this situation and whether and how it relates to a higher risk of precancerous lesions is open to debate.

25 May 2018 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Closed access
PDF file
AFAlessandra Falda
Alessandra Falda
PDPaolo Doretto
Paolo Doretto

Verified
Journal Article
Open access
PDF file
VDVeronica Davanzo
Veronica Davanzo
AFAlessandra Falda
Alessandra Falda
PFPaola Fogar
Paola Fogar
KLKathrin Ludwig
Kathrin Ludwig
JZJenny Zuin
Jenny Zuin
Daniela BassoDaniela Basso
Daniela Basso
Breast Implant-Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL) is a rare T-cell non-Hodgkin lymphoma associated with breast prosthetic implants and represents a diagnostic challenge. The National Comprehensive Cancer Network (NCCN) guidelines, updated in 2024, recommend for diagnosis an integrated work-up that should include cell morphology, CD30 immunohistochemistry (IHC), and flow cytometry (FCM). CD30 IHC, although the test of choice for BIA-ALCL diagnosis, is not pathognomonic, and this supports the recommendation to apply a multidisciplinary approach. A close collaboration between pathologists and laboratory professionals allowed the diagnosis of three BIA-ALCLs, presented as case reports, within a series of 35 patients subjected to periprosthetic effusions aspiration from 2018 to 2023. In one case, rare neoplastic cells were identified by FCM, and this result was essential in leading the anatomopathological picture as indicative of this neoplasm. In fact, the distinction between a lymphomatous infiltrate from reactive cells may be very complex in the cytopathology and IHC setting when neoplastic cells are rare. On the other hand, one limitation of FCM analysis is the need for fresh samples. In this study, we provide evidence that a dedicated fixative allows the maintenance of an unaltered CD30 expression on the cell surface for up to 72 h.

1 April 2003 in Gastroenterology
Verified
Journal Article
Open access
PDF file
PFPaola Fogar
Paola Fogar
CZCarlo-Federicio Zambon
Carlo-Federicio Zambon
Daniela BassoDaniela Basso
Daniela Basso
FNFilippo Navaglia
Filippo Navaglia
EGEliana Greco
Eliana Greco
Mario PlebaniMario Plebani
Mario Plebani
Cytokines genes polymorphisms have been suggested to favor cancer onset in response to\ud triggering factors and drive tumor progression. The aims of this study were to: 1. evaluate\ud IL-lb-31, IL-1RN (VNTR intron 2), CTGF-447, IFNg + 874, TNFa-1031, TNFa-863, TNFa-\ud 857, TNFa-308, 1L-10-1082, IL-10-819, IL-10-592 genes polymorphisms in patients with\ud PC or chronic pancreatitis (CP) in comparison with controls (CS); 2. ascertain whether any\ud of the above genes polymorphisms were associated with any clinical aspect of PC Patients:\ud 60 with PC (28 metastatic and 32 locally advanced; 16 had normal glucose tolerance, 7\ud glucose intollerance and 37 frank diabetes melfitus); 30 with CP and 78 CS. Genomic DNA\ud was extracted from whole blood; all cytokines genes polyraorphisms were PCR amplified and, excepted for 1L-1RN, were RFLP analysed. Only [L-10-819 and IL-10-592 were in\ud complete linkage. A higher frequency of IL-1b-31 T/T genotype was found in CP (57%) as\ud compared to CS (35%) or PC (42%). In PC (43%) and CP (41%) with respect to CS (31%)\ud a higher frequency of 1L-10-1082 A/A genotype was found (Chi-square= 11.43, p<0.05).\ud None of the studied polymorphisms was correlated with tumor stage or grade. Considering\ud PC and CP all together (Chi-square = 15.7, p<0.01), or PC alone (Chi-square = 21.4,\ud p<0.001), an association was found between TNFa-863 A allele and diabetes mellitus.\ud Considering PC patients, TNFa-1031 T/T was associated with a slightly higher frequency\ud of metastases (79%) after surgery, in comparison with C/T genotype (55%). Survival was\ud correlated only to tumor stage (Chi-square = 14.48, p<0.O1), but not to any cytokine studied\ud polymorphism Conclusions: lL-lb-31 and IL10-1082 gene polymorphisms might drive the\ud onset of pancreatic cancer or chronic pancreatitis in response to triggering events, as already\ud described for gastric or prostate cancer; TNFa-863 gene polymorphism seems that mainly\ud involved in favoring diabetes development in patients with PC. Cytokines gene polymorphisms\ud do not seem involved in affecting PC patients survival: only tumor stage was confirmed\ud to predict the outcome of these patients

Verified
Journal Article
Open access
PDF file
AFAlessandra Falda
Alessandra Falda
Macrophages are highly plastic innate immune cells that adopt context-dependent phenotypes along a continuum, integrating developmental origin with local microenvironmental cues rather than conforming to discrete M1/M2 states. This review delineates the molecular circuits shaping macrophage identity—TLR/cytokine signaling, microRNA networks, metabolic rewiring, and epigenetic mechanisms including histone lactylation—and traces how circulating monocyte subsets contribute to tissue macrophage diversity. We examine macrophage plasticity across a broad disease spectrum—oncology, autoimmune and rheumatic diseases, inflammatory bowel disease, infectious diseases, metabolic disorders, and neurological conditions—showing that the pathogenic phenotype is strikingly context-dependent: for instance, M2-like tumor-associated macrophages promote immune evasion in solid tumors, whereas M1-skewed programs drive tissue damage in autoimmunity. Soluble markers (sCD163, sCD14, soluble mannose receptor) are emerging biomarkers of disease activity and prognosis. High-dimensional flow cytometry and mass cytometry (CyTOF) bridge molecular biology and clinical phenotyping, enabling integrated readouts of surface phenotype, intracellular signaling, and metabolic state. Therapeutic strategies discussed include selective tumor-associated macrophage (TAM) reprogramming, chimeric antigen receptor (CAR)-M cell therapies, and biomaterial-based platforms. Future priorities encompass spatially resolved multi-omics, epigenetic and metabolic targeting, and macrophage-centered vaccine approaches. Standardized cytometry panels will be essential for biomarker-guided stratification and context-specific interventions.

Verified
Journal Article
Open access
PDF file
AFAlessandra Falda
Alessandra Falda
Despite the use of molecular tests and imaging techniques, flow cytometry continues to capture attention in various fields today